GL1X · GenesisL1 explorer

MolNFT v1 · #182480 · protein

Crystal structure of R73A mutant of CG10062 with a covalent intermediate of the hydration of acetylenecarboxylic acid

7MS3 · 4-oxalocrotonate tautomerase: “Crystal structure of R73A mutant of CG10062 with a covalent intermediate of the hydration of…”. X-ray diffraction, 1 ligand (3OH), 1 pocket (best druggability 0.62). MolNFT v1 #182480 on GenesisL1: 3D…

PDB
7MS3
Type
protein
Length
144 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
4-oxalocrotonate tautomerase
UniProt
A0A0S2T163
Ligands
3OH
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A4-oxalocrotonate tautomeraseprotein14443% helix, 26% strandA0A0S2T163

Ligands and binding sites

  • 3OH · 3-hydroxy-propanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11600.620.84263OH

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7MS3 · Crystal structure of R73A mutant of Cg10062 with a covalent intermediate of the hydration… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.